Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 9/20 | 0.39 |
| ▸ | GRM5 | P41594 | 1/20 | 0.38 |
| ▸ | ASIC3 | Q9UHC3 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | ACACB | O00763 | 1/20 | 0.35 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.35 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.34 |
| ▸ | MMP3 | P08254 | 1/20 | 0.34 |
| ▸ | IDO1 | P14902 | 1/20 | 0.34 |
| ▸ | APP | P05067 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23986576 | 0.94 | ACACB (0.38) | ALDH1A1RECQLGAAACACBMMP3 | |
| SCHEMBL30536490 | 0.91 | ASIC3 (0.44) | FFAR1GRM5ASIC3ALDH1A1RECQL | |
| SCHEMBL30536496 | 0.91 | ASIC3 (0.44) | FFAR1GRM5ASIC3ALDH1A1RECQL | |
| SCHEMBL21858952 | 0.91 | ASIC3 (0.44) | FFAR1GRM5ASIC3ALDH1A1RECQL | |
| SCHEMBL23965441 | 0.85 | IDO1 (0.45) | FFAR1GRM5ASIC3ALDH1A1RECQL | |
| SCHEMBL30536495 | 0.84 | IDO1 (0.44) | ASIC3ALDH1A1RECQLACACBMMP3 | |
| SCHEMBL21858514 | 0.84 | IDO1 (0.44) | ASIC3ALDH1A1RECQLACACBMMP3 | |
| SCHEMBL30536494 | 0.84 | IDO1 (0.44) | ASIC3ALDH1A1RECQLACACBMMP3 | |
| SCHEMBL31290261 | 0.84 | ESR1 (0.42) | ALDH1A1RECQLGAAIDO1 | |
| SCHEMBL23986581 | 0.82 | CYP1A1 (0.46) | ASIC3ALDH1A1RECQLACACBMMP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210355058-A1 | POLYCYCLIC COMPOUNDS | MITSUBISHI GAS CHEMICAL CO (JP) | 2021-11-18 | — | — | US | disclosed |
| US-20210340317-A1 | POLYCYCLIC COMPOUNDS | REUTER CHEMISCHE APPARATEBAU E.K. (DE) | 2021-11-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210340317-A1 | POLYCYCLIC COMPOUNDS | CBR1, C1R, CBR3 | FFAR1 373/4885GRM5 2617/4885ASIC3 1634/4885 |
| US-20210355058-A1 | POLYCYCLIC COMPOUNDS | CBR1, CBR3, C1R | FFAR1 260/4885GRM5 2703/4885ASIC3 1443/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.